Prevention of age related macular degeneration. Current evidence suggests that vitamin E alone is unlikely to have a large protective effect
Prevention of age related macular degeneration. Current evidence suggests that vitamin E alone is unlikely to have a large protective effect
Age related macular degeneration may be recognised in its early stages by the appearance of drusen and pigment change within the retina, but it produces few symptoms. Progression of age related macular degeneration can result in irreversible visual loss and is the commonest cause of blindness in the Western world. New treatments such as photodynamic therapy and macular surgery may limit the extent of visual loss and in a few cases even restore sight.1 But in contrast with cataract surgery, outcomes are unpredictable and the treatment is burdensome for patients and carries massive resource implications for healthcare providers. The prospect of prevention is thus very appealing from the public health perspective, not to mention that of the patient who may be at risk of losing the ability to recognise faces, read a newspaper, or to live independently. Increasing evidence suggests that cumulative oxidative damage increases risk of age related.
1-2
Hall, Nigel F.
cd32d48e-a60b-4a7e-b1a2-99cfb8c68c58
Gale, Catharine R.
5bb2abb3-7b53-42d6-8aa7-817e193140c8
2002
Hall, Nigel F.
cd32d48e-a60b-4a7e-b1a2-99cfb8c68c58
Gale, Catharine R.
5bb2abb3-7b53-42d6-8aa7-817e193140c8
Hall, Nigel F. and Gale, Catharine R.
(2002)
Prevention of age related macular degeneration. Current evidence suggests that vitamin E alone is unlikely to have a large protective effect.
BMJ, 325 (7354), .
(doi:10.1136/bmj.325.7354.1).
Abstract
Age related macular degeneration may be recognised in its early stages by the appearance of drusen and pigment change within the retina, but it produces few symptoms. Progression of age related macular degeneration can result in irreversible visual loss and is the commonest cause of blindness in the Western world. New treatments such as photodynamic therapy and macular surgery may limit the extent of visual loss and in a few cases even restore sight.1 But in contrast with cataract surgery, outcomes are unpredictable and the treatment is burdensome for patients and carries massive resource implications for healthcare providers. The prospect of prevention is thus very appealing from the public health perspective, not to mention that of the patient who may be at risk of losing the ability to recognise faces, read a newspaper, or to live independently. Increasing evidence suggests that cumulative oxidative damage increases risk of age related.
This record has no associated files available for download.
More information
Published date: 2002
Additional Information:
Papers p 11
Identifiers
Local EPrints ID: 25580
URI: http://eprints.soton.ac.uk/id/eprint/25580
ISSN: 0959-8138
PURE UUID: da4981a7-1fae-44dd-84ab-835669081c75
Catalogue record
Date deposited: 19 Apr 2006
Last modified: 16 Mar 2024 02:49
Export record
Altmetrics
Contributors
Author:
Nigel F. Hall
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics